Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Biocity Investments Limited investment portfolio
Biocity Investments Limited has made numerous investments in companies such as Enterobiotix, Novosound, and Nanosyrinx within the Biotech sector.
vc
Portfolio
6
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (6)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Bivictrix Therapeutics Limited BiVictriX Therapeutics develops next‑generation multispecific antibody‑drug conjugates (ADCs) using its proprietary Bi‑Cygni® platform to create highly cancer‑selective therapies for solid tumours and haematological malignancies. | Healthcare & Life Sciences | Macclesfield | Confirmed | 2025-06-21 |
| Enterobiotix Limited EnteroBiotix is a clinical‑stage biopharmaceutical company developing orally delivered, full‑spectrum microbiome therapeutics, with its lead product EBX‑102‑02 being evaluated for irritable bowel syndrome and other gastrointestinal and liver diseases. | Healthcare & Life Sciences | Bellshill | Confirmed | 2025-04-19 |
Shareholding changes (4)
Biocity Investments Limited's positions across portfolio companies2026
- ORDINARY 0 → 2,284,527
- A ORDINARY 0 → 10,299
Articles (2)
- 20 Jun 2026
- 9 May 2026